Legal & IP
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Legal Issues
Agency hears from experts on whether PBMs and group purchasing organizations operate under misaligned incentives.
As Concordia finds itself in the dock again, this time over its pricing of the essential thyroid treatment liothyronine, the UK's Competition and Markets Authority has recently opened four new investigations into "suspected abuse of dominance" concerning generics.
A description of the patent challenge proceeding and how it differs from district court litigation.
Supreme Court to consider whether Patent Trial and Appeal Board must address all patent claims challenged in an inter partes review petition.
Biopharma and generic industries stand on opposing sides in case that could eliminate the patent challenge proceeding. Interactive timeline covers IPR's five-year history leading to oral arguments Nov. 27.
Negotiations over Brexit and a legal challenge lodged in Germany are holding up progress with establishing the proposed Unified Patent Court, and could also affect plans for an EU-wide supplementary protection certificate, according to legal experts.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.